MALDI-TOF mass spectrometry for quantitative, specific, and sensitive analysis of DNA and RNA

Annals of the New York Academy of Sciences

Volumn 1075, Issue , 2006, Pages 282-287

  Ding, Chunming ^a   Lo, Yuk Ming Dennis ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

MALDI TOF mass spectrometry; Plasma DNA; Plasma RNA; Prenatal diagnosis

Indexed keywords

DNA; RNA;

BLOOD CELL; BLOOD LEVEL; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CELL FREE SYSTEM; CONFERENCE PAPER; DIAGNOSTIC IMAGING; DNA CONTENT; DNA DETERMINATION; FETUS DISEASE; HUMAN; MATERNAL BLOOD; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEASUREMENT; MOTHER FETUS RELATIONSHIP; PROGNOSIS; QUANTITATIVE ANALYSIS; RNA ANALYSIS; SENSITIVITY AND SPECIFICITY; TUMOR CELL;

EID: 33749569202     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1368.038     Document Type: Conference Paper

References (40)

1. CHEN, X.Q. et al. 1996. Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat. Med. 2: 1033-1035.
2. AWROZ, H. et al. 1996. Microsatellite alterations in serum DNA of head and neck cancer patients. Nat. Med. 2: 1035-1037.
3. LO, Y.M. et al. 1997. Presence of fetal DNA in maternal plasma and serum. Lancet 350: 485-487.
4. KOPRESKI, M.S. et al. 1999. Detection of tumor messenger RNA in the serum of patients with malignant melanoma. Clin. Cancer Res. 5: 1961-1965.
5. CHEN, X.Q. et al. 2000. Telomerase RNA as a detection marker in the serum of breast cancer patients. Clin. Cancer Res. 6: 3823-3826.
6. NG, E.K. et al. 2003. mRNA of placental origin is readily detectable in maternal plasma. Proc. Natl. Acad. Sci. USA 100: 4748-4753.
7. LO, Y.M. et al. 1998. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am. J. Hum. Genet. 62: 768-775.
8. TANG, K. et al. 1999. Chip-based genotyping by mass spectrometry. Proc. Natl. Acad. Sci. USA 96: 10016-10020.
9. DING, C. & C.R. CANTOR. 2003. A high-throughput gene expression analysis technique using competitive PCR and matrix-assisted laser desorption ionization time-of-flight MS. Proc. Natl. Acad. Sci. USA 100: 3059-3064.
10. DING, C. & C.R. CANTOR. 2003. Direct molecular haplotyping of long-range genomic DNA with MI-PCR. Proc. Natl. Acad. Sci. USA 100: 7449-7453.
11. DING, C. et al. 2004. MS analysis of single-nucleotide differences in circulating nucleic acids: application to noninvasive prenatal diagnosis. Proc. Natl. Acad. Sci. USA 101: 10762-10767.
12. DING, C. et al. 2004. Simultaneous quantitative and allele-specific expression analysis with real competitive PCR. BMC Genet. 5: 8.
13. LO, Y.M. et al. 1998. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N. Engl. J. Med. 339: 1734-1738.
14. GAUTIER, E. et al. 2005. Fetal RhD genotyping by maternal serum analysis: a two-year experience. Am. J. Obstet. Gynecol. 192: 666-669.
15. CHIU, R.W. et al. 2002. Prenatal exclusion of beta thalassaemia major by examination of maternal plasma. Lancet 360: 998-1000.
16. LI, Y. et al. 2004. Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms. Clin. Chem. 50: 1002-1011.
17. GIBSON, U.E. & C.A. HEID et al. 1996. A novel method for real time quantitative RT-PCR. Genome Res. 6: 995-1001.
18. JOHNSON, K.L. et al. 2004. Interlaboratory comparison of fetal male DNA detection from common maternal plasma samples by real-time PCR. Clin. Chem. 50: 516-521.
19. BROJER, E. et al. 2005. Noninvasive determination of fetal RHD status by examination of cell-free DNA in maternal plasma. Transfusion 45: 1473-1480.
20. SEKIZAWA, A. et al. 2001. Accuracy of fetal gender determination by analysis of DNA in maternal plasma. Clin. Chem. 47: 1856-1858.
21. FINNING, K.M. et al. 2002. Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service. Transfusion 42: 1079-1085.
22. COSTA, J.M. et al. 2001. First-trimester fetal sex determination in maternal serum using real-time PCR. Prenat. Diagn. 21: 1070-1074.
23. RIJNDERS, R.J. et al. 2004. Clinical applications of cell-free fetal DNA from maternal plasma. Obstet. Gynecol. 103: 157-164.
24. NASIS, O. et al. 2004. Improvement in sensitivity of allele-specific PCR facilitates reliable noninvasive prenatal detection of cystic fibrosis. Clin. Chem. 50: 694-701.
25. CHAN, K.C. et al. 2004. Size distributions of maternal and fetal DNA in maternal plasma. Clin. Chem. 50: 88-92.
26. LI, Y. et al. 2004. Improved prenatal detection of a fetal point mutation for achondroplasia by the use of size-fractionated circulatory DNA in maternal plasma-case report. Prenat. Diagn. 24: 896-898.
27. LI, Y. et al. 2005. Detection of paternally inherited fetal point mutations for beta-thalassemia using size-fractionated cell-free DNA in maternal plasma. JAMA 293: 843-849.
28. ELVIDGE, G.P. et al. 2005. Development and evaluation of real competitive PCR for high-throughput quantitative applications. Anal. Biochem. 339: 231-241.
29. YANG, H. et al. 2005. Sensitive detection of human papillomavirus in cervical, head/neck, and schistosomiasis-associated bladder malignancies. Proc. Natl. Acad. Sci. USA 102: 7683-7688.
30. LIU, J. et al. 2005. SARS transmission pattern in Singapore reassessed by viral sequence variation analysis. PLoS Med. 2: e43.
31. LEUNG, T.N. et al. 2001. Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia. Clin. Chem. 47: 137-139.
32. LO, Y.M. et al. 1999. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin. Chem. 45: 184-188.
33. LEVINE, R.J. et al. 2004. Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. Am. J. Obstet. Gynecol. 190: 707-713.
34. LO, Y.M. et al. 1999. Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses withtrisomy 21. Clin. Chem. 45: 1747-1751.
35. ZHONG, X.Y. et al. 2000. Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses. Prenat. Diagn. 20: 795-798.
36. ZHONG, X.Y. et al. 2000. High levels of fetal erythroblasts and fetal extracellular DNA in the peripheral blood of a pregnant woman with idiopathic polyhydramnios: case report. Prenat. Diagn. 20: 838-841.
37. LEUNG, T.N. et al. 1998. Maternal plasma fetal DNA as a marker for preterm labour. Lancet 352: 1904-1905.
38. LAU, T.K. et al. 2000. Cell-free fetal deoxyribonucleic acid in maternal circulation as a marker of fetal-maternal hemorrhage in patients undergoing external cephalic version near term. Am. J. Obstet. Gynecol. 183: 712-716.
39. SEKIZAWA, A. et al. 2002. Increased cell-free fetal DNA in plasma of two women with invasive placenta. Clin. Chem. 48: 353-354.
40. SEKIZAWA, A. et al. 2001. Cell-free fetal DNA is increased in plasma of women with hyperemesis gravidarum. Clin. Chem. 47: 2164-2165.